Log in to save to my catalogue

Beta-Blocker Exposure and Survival in Patients With Transthyretin Amyloid Cardiomyopathy

Beta-Blocker Exposure and Survival in Patients With Transthyretin Amyloid Cardiomyopathy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2600824493

Beta-Blocker Exposure and Survival in Patients With Transthyretin Amyloid Cardiomyopathy

About this item

Full title

Beta-Blocker Exposure and Survival in Patients With Transthyretin Amyloid Cardiomyopathy

Publisher

England: Elsevier Inc

Journal title

Mayo Clinic proceedings, 2022-02, Vol.97 (2), p.261-273

Language

English

Formats

Publication information

Publisher

England: Elsevier Inc

More information

Scope and Contents

Contents

To investigate a potential association between beta-blocker exposure and survival in patients with transthyretin amyloid cardiomyopathy (ATTR-CM).
In this real-world prospective registry of 128 consecutive patients with ATTR-CM recruited in 7 institutions in Galicia (Spain), survival of 65 patients who received beta blockers on registry enrollme...

Alternative Titles

Full title

Beta-Blocker Exposure and Survival in Patients With Transthyretin Amyloid Cardiomyopathy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2600824493

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2600824493

Other Identifiers

ISSN

0025-6196

E-ISSN

1942-5546

DOI

10.1016/j.mayocp.2021.08.006

How to access this item